Public market investors
Biotech Investor · 16 portfolio companies
Portfolio
16
Combined Value
$795.2B
Focus Areas
28
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Sumitomo Pharma | $736.8B |
| CSPC Innovation Pharmaceutical | $42.4B |
| Xenon Pharmaceuticals | $5.2B |
| Dyne Therapeutics | $2.9B |
| Sionna Therapeutics | $1.6B |
| Fagron | $1.6B |
| Ardelyx | $1.3B |
| Annexon | $761.7M |
| Personalis | $759.6M |
| CytomX Therapeutics | $757.3M |
| Fulcrum Therapeutics | $450.9M |
| PharmaSGP | $380M |
| Transgene SA | $204.9M |
| Milestone Pharmaceuticals | $115.8M |
| Addex Therapeutics | $7.0M |
| Unity Biotechnology | $3.4M |